Posts

Welcome to the Fritsma Factor, please join our hemostasis discussions.

A hypothetical case study: a patient whose birthdate was 9-20-1945 had ESRD and non-valvular atrial...
Mar 23, 2017 1:08pm
From Heather DeVries. Hi George! Do you know the reasoning behind using a 2-hour vs 1-hour...
Mar 21, 2017 5:57pm
From Heather DeVries: Greetings! We were inspected by CAP this week, and at one facility they...
Mar 21, 2017 5:44pm
Here is an editorial that appeared in the December, 2016 Journal of Thrombosis and Haemostasis...
Mar 21, 2017 4:38pm
Mar 23, 2017 1:08pm
A hypothetical case study: a patient whose birthdate was 9-20-1945 had ESRD and non-valvular atrial fibrillation. He had been on renal dialysis since 2011 and had been taking Coumadin since 2005, maintaining an INR
0 Comments
Mar 21, 2017 5:57pm
From Heather DeVries. Hi George! Do you know the reasoning behind using a 2-hour vs 1-hour incubation in mixing studies? We have always used 2 hours, and I wonder if it has to do with the heterogeneity of the antibodies we are trying to pick up. Our pathologist probably has a very good explanation, but I thought it would be interesting to hear from others on what they do and why. Thanks, Heather.
2 Comments
Mar 21, 2017 5:44pm
From Heather DeVries: Greetings! We were inspected by CAP this week, and at one facility they questioned the validation of PPP. Our current procedure, written in 2001, states that the AVERAGE of 10 specimens
2 Comments
Mar 21, 2017 4:38pm
Here is an editorial that appeared in the December, 2016 Journal of Thrombosis and Haemostasis describing the thinking that led to a coagulation factor VIII mimetic. This is a bispecific antibody that approximates factors IX and X to activate X while bypassing factor VIII. Designated ACE910, the mimetic enables normal clotting in hemophilia A when an inhibitor is present.
0 Comments